286 related articles for article (PubMed ID: 20190758)
1. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.
Semmling V; Lukacs-Kornek V; Thaiss CA; Quast T; Hochheiser K; Panzer U; Rossjohn J; Perlmutter P; Cao J; Godfrey DI; Savage PB; Knolle PA; Kolanus W; Förster I; Kurts C
Nat Immunol; 2010 Apr; 11(4):313-20. PubMed ID: 20190758
[TBL] [Abstract][Full Text] [Related]
2. Signal 0 for guided priming of CTLs: NKT cells do it too.
Bousso P; Albert ML
Nat Immunol; 2010 Apr; 11(4):284-6. PubMed ID: 20300136
[No Abstract] [Full Text] [Related]
3. Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming.
Osmond TL; Farrand KJ; Painter GF; Ruedl C; Petersen TR; Hermans IF
J Immunol; 2015 Aug; 195(3):821-31. PubMed ID: 26078270
[TBL] [Abstract][Full Text] [Related]
4. Suppression of murine tumour growth through CD8
Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
6. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1.
Yamazaki C; Sugiyama M; Ohta T; Hemmi H; Hamada E; Sasaki I; Fukuda Y; Yano T; Nobuoka M; Hirashima T; Iizuka A; Sato K; Tanaka T; Hoshino K; Kaisho T
J Immunol; 2013 Jun; 190(12):6071-82. PubMed ID: 23670193
[TBL] [Abstract][Full Text] [Related]
7. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
Stober D; Jomantaite I; Schirmbeck R; Reimann J
J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
[TBL] [Abstract][Full Text] [Related]
8. BCR-ABL-specific CD4
Ueda N; Zhang R; Tatsumi M; Liu TY; Kitayama S; Yasui Y; Sugai S; Iwama T; Senju S; Okada S; Nakatsura T; Kuzushima K; Kiyoi H; Naoe T; Kaneko S; Uemura Y
Cell Mol Immunol; 2018 Jan; 15(1):15-26. PubMed ID: 27181332
[TBL] [Abstract][Full Text] [Related]
9. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury.
Heymann F; Meyer-Schwesinger C; Hamilton-Williams EE; Hammerich L; Panzer U; Kaden S; Quaggin SE; Floege J; Gröne HJ; Kurts C
J Clin Invest; 2009 May; 119(5):1286-97. PubMed ID: 19381017
[TBL] [Abstract][Full Text] [Related]
10. TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells.
Iyori M; Zhang T; Pantel H; Gagne BA; Sentman CL
J Immunol; 2011 Sep; 187(6):3087-95. PubMed ID: 21832159
[TBL] [Abstract][Full Text] [Related]
11. Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination.
Matsuyoshi H; Senju S; Hirata S; Yoshitake Y; Uemura Y; Nishimura Y
J Immunol; 2004 Jan; 172(2):776-86. PubMed ID: 14707047
[TBL] [Abstract][Full Text] [Related]
12. A retrogen strategy for presentation of an intracellular tumor antigen as an exogenous antigen by dendritic cells induces potent antitumor T helper and CTL responses.
You Z; Hester J; Rollins L; Spagnoli GC; van der Bruggen P; Chen SY
Cancer Res; 2001 Jan; 61(1):197-205. PubMed ID: 11196161
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between iNKT cells and CD8 T cells in the spleen requires the IL-4/CCL17 axis for the generation of short-lived effector cells.
Valente M; Dölen Y; van Dinther E; Vimeux L; Fallet M; Feuillet V; Figdor CG
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25816-25827. PubMed ID: 31796596
[TBL] [Abstract][Full Text] [Related]
14. How to connect an IgE-driven response with CTL activity?
Platzer B; Dehlink E; Turley SJ; Fiebiger E
Cancer Immunol Immunother; 2012 Sep; 61(9):1521-5. PubMed ID: 22042251
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 3 promotes cross-priming to virus-infected cells.
Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C
Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573
[TBL] [Abstract][Full Text] [Related]
16. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
Scheu S; Ali S; Ruland C; Arolt V; Alferink J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells and regulatory T cells expressing CCR4 provide resistance to coxsackievirus B5-induced pancreatitis.
Françozo MCS; Costa FRC; Guerra-Gomes IC; Silva JS; Sesti-Costa R
Sci Rep; 2019 Oct; 9(1):14766. PubMed ID: 31611578
[TBL] [Abstract][Full Text] [Related]
18. CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis.
Heiseke AF; Faul AC; Lehr HA; Förster I; Schmid RM; Krug AB; Reindl W
Gastroenterology; 2012 Feb; 142(2):335-45. PubMed ID: 22057112
[TBL] [Abstract][Full Text] [Related]
19. Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells.
Johnson S; Zhan Y; Sutherland RM; Mount AM; Bedoui S; Brady JL; Carrington EM; Brown LE; Belz GT; Heath WR; Lew AM
Immunity; 2009 Feb; 30(2):218-27. PubMed ID: 19200758
[TBL] [Abstract][Full Text] [Related]
20. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
Lorenzi S; Mattei F; Sistigu A; Bracci L; Spadaro F; Sanchez M; Spada M; Belardelli F; Gabriele L; Schiavoni G
J Immunol; 2011 May; 186(9):5142-50. PubMed ID: 21441457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
